Pancreatic Cancer Action Network receives $25 million gift

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Pancreatic Cancer Action Network said it has received a $25 million gift—the largest donation in the history of the organization. The gift was made to honor the memory of Skip Viragh, one of the country’s most influential mutual fund investment experts, who died in 2003.

PanCAN said it will use the multimillion dollar gift to advance its existing programs and services, including the launch of its clinical trial platform Precision PromiseSM, as well as early detection efforts, the Know Your Tumor molecular profiling service, patient services and research.

Another $15 million gift was made to PanCAN in 2015 in Skip’s memory. That gift led the organization’s goal to raise $200 million by 2020 and to launch initiatives considered critical to transforming patient outcomes, such as the Know Your Tumor precision medicine service and the Patient Registry.

YOU MAY BE INTERESTED IN

Recently, HHS Secretary Robert F. Kennedy Jr. posted a video montage featuring himself shirtless in jeans, working out with Kid Rock. The duo is in a blue-lit grotto with a cold plunge and sauna. Set to Kid Rock’s “Bawitdaba” and intercut with a selection of patriotic imagery, the video ends with the two men in a hot tub, chugging what appears to be milk.
In January, FDA released a draft guidance entitled “Minimal Residual Disease and Complete Response in Multiple Myeloma: Use as Endpoints to Support Accelerated Approval.” This release came roughly 20 months after the Oncologic Drugs Advisory Committee (ODAC) voted unanimously that minimal residual disease (MRD) negativity, in combination with complete response (CR), is an acceptable primary endpoint to support accelerated approval for multiple myeloma (MM) therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login